Latest Corporate Mergers And Acquisitions News

SGH Ltd reported a solid half-year profit of $472.6 million, declaring a fully franked 32 cent dividend, while completing a major media merger that reshapes its investment portfolio.

Seven West Media Limited shares have been suspended from the ASX following court approval of its acquisition by Southern Cross Media Group, marking a significant shift in Australian media ownership.

The Supreme Court of New South Wales has approved Southern Cross Media's acquisition of Seven West Media, setting the stage for a significant media industry consolidation early next year.

Prophecy International Holdings reported a 5% revenue decline and a 53% increase in net loss for FY25, while advancing key product developments and announcing a transformative merger with Complexica.

Sayona Mining delivered record lithium concentrate production and sales in FY25, driving revenue to $223 million despite a 16% drop in selling prices. The company also recorded a significant $271 million impairment on its North American Lithium assets amid weaker market conditions.

SPC Global reports stronger-than-expected FY25 results driven by international growth and synergy gains, while unveiling a new premium beverage division and a major lender transition.

Vonex Limited shareholders are set to vote on a court-approved scheme of arrangement for Maxo Telecommunications to acquire the remaining 30.6% stake, offering a significant premium. The scheme promises a timely cash exit amid sector uncertainties.

MIXI Australia has extended its takeover offer for PointsBet shares to 29 August 2025 and announced a conditional increase in the offer price from $1.25 to $1.30 per share, aiming to secure at least 90% ownership.

PointsBet Holdings has received an unsolicited all-scrip takeover offer from Betr Entertainment valuing its shares at $1.03, but the board advises shareholders to hold off action while backing a superior $1.20 cash offer from MIXI.

Mayne Pharma has dismissed a fresh termination notice from Cosette Pharmaceuticals, reaffirming its commitment to proceed with the upcoming Scheme Meeting on 18 June 2025. The dispute centers on the validity of the Scheme Implementation Deed termination claims.

Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.

Vitasora Health Limited reports a striking 101% revenue increase and 57% patient growth in Q1 2025, driven by new Medicare Shared Savings Plan contracts and significant operational efficiencies from its Orb Health merger.